Navigation Links
Catalyst Pharmaceutical Partners Reports First Quarter 2009 Financial Results
Date:5/14/2009

by the U.S. Food & Drug Administration (FDA) for the treatment of cocaine addiction. This indicates that the FDA has recognized that CPP-109 is intended for the treatment of a serious or life-threatening condition for which there is no effective treatment and which demonstrates the potential to address unmet medical needs. For more information about the Company, go to www.catalystpharma.com.

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties which may cause the Company's actual results in future periods to differ materially from forecasted results. A number of factors, including our ability to successfully complete the clinical trials required for us to file a new drug application for CPP-109, our ability to complete such trials on a timely basis within the budgets we establish for such trials, our ability to protect our intellectual property and those other factors described in the Company's Annual Report on Form 10-K for 2008 and the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2009 that the Company has filed with the U.S. Securities and Exchange Commission ("SEC"), could adversely affect the Company. Copies of the Company's filings with the SEC are available from the SEC, may be found on the Company's website or may be obtained upon request from the Company. The Company does not undertake any obligation to update the information contained herein, which speaks only as of this date.


                    CATALYST PHARMACEUTICAL PARTNERS, INC.
                        (a development stage company)

                 CONDENSED STATEMENTS OF OPERATIONS (unaudited)

                                             For the Three Months Ended
                                                      March 31,
                                 
'/>"/>
SOURCE Catalyst Pharmaceutical Partners, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Catalyst Pharmaceutical Partners Reports Third Quarter 2007 Financial Results
4. Catalyst Pharmaceutical Partners Announces Positive Phase II Trial Results for Vigabatrin in the Treatment of Cocaine Addiction
5. CATalyst Summit Declared a Success: Its All About the Cat!
6. Cardiva Medical, Inc. to Present Highlights of the Boomerang Catalyst(TM) II System at the Investment in Innovation (In3) West Conference on February 29, 2008 in Las Vegas, NV
7. Catalyst Pharmaceutical Partners, Inc. Names Director - Corporate Clinical Compliance
8. Case in Point: Patient Control of Data Critical Catalyst for Online Health Care Revolution
9. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
10. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
11. CATalyst Council Forms to Address Feline Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... is the event of the year for the latest ... of the Acute Cardiovascular Care Association (ACCA) of the ... October in Geneva, Switzerland. , Monday 16 September ... the specialty of cardiology dealing with acute problems in ... and acute heart failure. The scientific programme is available ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 According ... Market Research "Latin America Home Healthcare Market (By ... Healthcare Devices, Mobility Assist Devices and Medical Supplies; ... Infusion Therapy and Unskilled Home Healthcare Services) - ... 2014 - 2020" the Latin American Home Healthcare ...
(Date:9/16/2014)... VA (PRWEB) September 16, 2014 Norfolk, ... of delectable gluten-free and allergy friendly desserts, announced today ... for Breast Cancer Awareness Month this October. In support ... eliminating cancer, Lucy’s® will provide a charitable donation in ... one of the most common cancers among women in ...
(Date:9/16/2014)... HealthDay Reporter , MONDAY, Sept. 15, ... face a higher risk of developing an aggressive type of ... suggests. But, the study authors noted that it,s not ... should be concerned. Their study only found an association between ... prove cause and effect. "It is conceivable that, in ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Current students ... the Capstone Event in Yelm, Washington, Oct. 20-26 to ... the year and caps off the remarkable “Masters of ... world in Switzerland, Italy, Australia, South Korea, Mexico, and ... half price for children ages 6-19 and for seniors ...
Breaking Medicine News(10 mins):Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 2Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Health News:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 2Health News:Lucy’s Joins Fight Against Breast Cancer With Launch Of Limited Edition Packaging And Charitable Donation 3Health News:Male Pattern Baldness Tied to Prostate Cancer, Study Suggests 2Health News:Male Pattern Baldness Tied to Prostate Cancer, Study Suggests 3Health News:Ramtha School Presents Capstone Event in Yelm Oct. 20-26 2
... extensively drug-resistant tuberculosis (XDR TB) in the United States, ... and difficult-to-treat disease between 1993 and 2006, and 77 ... The study appears in the August 15 issue of ... California reports almost 3,000 cases of tuberculosis annually, the ...
... benefits are weighed , , WEDNESDAY, Aug. 13 (HealthDay ... suggests. , Would-be participants in an extramarital affair tend ... researchers from the University of New Hampshire (UNH) and ... the decision differ slightly between men and women, said ...
... Network Growing, BUFFALO, N.Y., Aug. 13 ... national, electronic healthcare network,and has announced the ... healthcare providers., (Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NYW083LOGO ... Medina Memorial Health Care,System, and MedFirst Urgent ...
... and Two Rivers among Thomson ... MILWAUKEE, Aug. 13 Three Aurora Health Care facilities,are ... having,demonstrated the fastest, most consistent improvement over five consecutive,years., ... Medical Center of,Green Bay were ranked in the Thomson ...
... a,lazy Sunday with a great meal and relaxing spa treatments. Voda ... Sunday, from 12pm - 4pm, Voda Spa offers the taste and ... Brunch Massage $140 Brunch Scrub ... Choose from a selection of delicious dishes from our restaurant. All,brunches ...
... LAKE OSWEGO, Ore., Aug. 13 West Coast ... of LifeWorks Northwest, a,leading non-profit, community-based mental health ... pledge and a corporate gift. The donation,will sponsor ... Children and Youth Recreation Fund., Additionally, West ...
Cached Medicine News:Health News:Extensively drug-resistant tuberculosis found in California 2Health News:Men and Women Calculate Cost of Affairs 2Health News:Wolfson's HealthTransaction Network(R) Signs Four New Hospital Systems 2Health News:Three Aurora Hospitals Named Top Performers in National Thomson Reuters Annual Survey 2Health News:Three Aurora Hospitals Named Top Performers in National Thomson Reuters Annual Survey 3Health News:West Coast Bank Sponsors LifeWorks Northwest Programs for Children in Low-Income Housing Communities 2
(Date:9/15/2014)... Sept. 15, 2014 /PRNewswire-iReach/ -- "Spain Aesthetic Lasers ... key market data on the Spain Aesthetic Lasers ... in millions of US dollars, volume (in units) ... segments Invasive Body Contouring Devices (Laser-Assisted Liposuction (LAL) ... (RFAL) Devices, Ultrasound-Assisted Liposuction (UAL) Devices and Power ...
(Date:9/15/2014)... Sept. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... wholly owned subsidiary, Valeant Pharmaceuticals International, will redeem all ... its 6.75% Senior Notes due 2017, CUSIP Nos. 91911XAL8, ... and has mailed an irrevocable notice of redemption for ... copy of the irrevocable notice of redemption with respect ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire-iReach/ -- MedicOne Medical Response, ... services, has been selected by Inc. Magazine as ... America. Photo - http://photos.prnewswire.com/prnh/20140914/145997 ... list identifies successful, privately-held companies with the largest ... Response, one of only two ambulance companies to ...
Breaking Medicine Technology:Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5Valeant Announces Redemption of All of the Outstanding $500.0 Million Aggregate Principal Amount of its 6.75% Senior Notes due 2017 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 2MedicOne Medical Response Named to 2014 Inc. 5000 Fastest Growing Companies List 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: